A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

NCT05432583 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Herpes Simplex Type 2

Interventions

BIOLOGICAL: BNT163
OTHER: Placebo

Sponsor

BioNTech SE